49 related articles for article (PubMed ID: 12917637)
1. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.
Henriksen J; Aagesen TH; Maelandsmo GM; Lothe RA; Myklebost O; Forus A
Oncogene; 2003 Aug; 22(34):5358-61. PubMed ID: 12917637
[TBL] [Abstract][Full Text] [Related]
2. TP53 in Biology and Treatment of Osteosarcoma.
Synoradzki KJ; Bartnik E; Czarnecka AM; Fiedorowicz M; Firlej W; Brodziak A; Stasinska A; Rutkowski P; Grieb P
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503094
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma Multi-Omics Landscape and Subtypes.
Tang S; Roberts RD; Cheng L; Li L
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894336
[TBL] [Abstract][Full Text] [Related]
4. CNTNAP4 signaling regulates osteosarcoma disease progression.
Qin Q; Ramesh S; Gomez-Salazar M; Zhong L; Cherief M; Pratapneni A; Morris CD; McCarthy EF; Zhang X; James AW
NPJ Precis Oncol; 2023 Jan; 7(1):2. PubMed ID: 36599925
[TBL] [Abstract][Full Text] [Related]
5. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.
Niu J; Yan T; Guo W; Wang W; Ren T; Huang Y; Zhao Z; Yu Y; Chen C; Huang Q; Lou J; Guo L
Autophagy; 2023 Jun; 19(6):1693-1710. PubMed ID: 36451342
[TBL] [Abstract][Full Text] [Related]
6. mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase.
Decock A; Creytens D; Lefever S; Van der Meulen J; Anckaert J; De Ganck A; Deleu J; De Wilde B; Fierro C; Kuersten S; Luypaert M; Rottiers I; Schroth GP; Steyaert S; Vanderheyden K; Vanden Eynde E; Verniers K; Verreth J; Van Dorpe J; Vandesompele J
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232302
[TBL] [Abstract][Full Text] [Related]
7. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A; Salas S; Bertucci F; Sobinoff AP; Adélaïde J; Guille A; Finetti P; Noble JR; Churikov D; Chaffanet M; Lavit E; Pickett HA; Bouvier C; Birnbaum D; Reddel RR; Géli V
EMBO Mol Med; 2022 Oct; 14(10):e15859. PubMed ID: 35920001
[TBL] [Abstract][Full Text] [Related]
8. Targeting the COP9 signalosome for cancer therapy.
Du W; Zhang R; Muhammad B; Pei D
Cancer Biol Med; 2022 Mar; 19(5):573-90. PubMed ID: 35315259
[TBL] [Abstract][Full Text] [Related]
9. Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma.
Pandya PH; Cheng L; Saadatzadeh MR; Bijangi-Vishehsaraei K; Tang S; Sinn AL; Trowbridge MA; Coy KL; Bailey BJ; Young CN; Ding J; Dobrota EA; Dyer S; Elmi A; Thompson Q; Barghi F; Shultz J; Albright EA; Shannon HE; Murray ME; Marshall MS; Ferguson MJ; Bertrand TE; Wurtz LD; Batra S; Li L; Renbarger JL; Pollok KE
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32859084
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
[TBL] [Abstract][Full Text] [Related]
11. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Behjati S; Tarpey PS; Haase K; Ye H; Young MD; Alexandrov LB; Farndon SJ; Collord G; Wedge DC; Martincorena I; Cooke SL; Davies H; Mifsud W; Lidgren M; Martin S; Latimer C; Maddison M; Butler AP; Teague JW; Pillay N; Shlien A; McDermott U; Futreal PA; Baumhoer D; Zaikova O; Bjerkehagen B; Myklebost O; Amary MF; Tirabosco R; Van Loo P; Stratton MR; Flanagan AM; Campbell PJ
Nat Commun; 2017 Jun; 8():15936. PubMed ID: 28643781
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of
Pang J; Yan X; Cao H; Qian L; He H; Tian H; Han F; Wang G; Chen X; Zhao Y; Hu JF; Cui J
J Cancer; 2017; 8(7):1129-1136. PubMed ID: 28607586
[No Abstract] [Full Text] [Related]
13. Osteosarcoma Overview.
Lindsey BA; Markel JE; Kleinerman ES
Rheumatol Ther; 2017 Jun; 4(1):25-43. PubMed ID: 27933467
[TBL] [Abstract][Full Text] [Related]
14. Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.
Lorenz S; Barøy T; Sun J; Nome T; Vodák D; Bryne JC; Håkelien AM; Fernandez-Cuesta L; Möhlendick B; Rieder H; Szuhai K; Zaikova O; Ahlquist TC; Thomassen GO; Skotheim RI; Lothe RA; Tarpey PS; Campbell P; Flanagan A; Myklebost O; Meza-Zepeda LA
Oncotarget; 2016 Feb; 7(5):5273-88. PubMed ID: 26672768
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
Xiong Y; Wu S; Du Q; Wang A; Wang Z
Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
Morrow JJ; Khanna C
Crit Rev Oncog; 2015; 20(3-4):173-97. PubMed ID: 26349415
[TBL] [Abstract][Full Text] [Related]
17. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Perry JA; Kiezun A; Tonzi P; Van Allen EM; Carter SL; Baca SC; Cowley GS; Bhatt AS; Rheinbay E; Pedamallu CS; Helman E; Taylor-Weiner A; McKenna A; DeLuca DS; Lawrence MS; Ambrogio L; Sougnez C; Sivachenko A; Walensky LD; Wagle N; Mora J; de Torres C; Lavarino C; Dos Santos Aguiar S; Yunes JA; Brandalise SR; Mercado-Celis GE; Melendez-Zajgla J; Cárdenas-Cardós R; Velasco-Hidalgo L; Roberts CW; Garraway LA; Rodriguez-Galindo C; Gabriel SB; Lander ES; Golub TR; Orkin SH; Getz G; Janeway KA
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5564-73. PubMed ID: 25512523
[TBL] [Abstract][Full Text] [Related]
18. Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.
Kanamori M; Sano A; Yasuda T; Hori T; Suzuki K
J Exp Clin Cancer Res; 2012 Nov; 31(1):100. PubMed ID: 23199169
[TBL] [Abstract][Full Text] [Related]
19. The genetics of osteosarcoma.
Martin JW; Squire JA; Zielenska M
Sarcoma; 2012; 2012():627254. PubMed ID: 22685381
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.
Both J; Wu T; Bras J; Schaap GR; Baas F; Hulsebos TJ
PLoS One; 2012; 7(1):e30907. PubMed ID: 22292074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
